Januvia and Ritalin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Januvia (sitagliptin phosphate) and Ritalin (methylphenidate hydrochloride). Common drug interactions include weight increased among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Januvia and Ritalin. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.

What is Januvia?

Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.

What is Ritalin?

Ritalin has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,427 Ritalin users. Check the latest studies of Ritalin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

88 people who take Januvia and Ritalin together, and have interactions are studied.

Januvia and Ritalin drug interactions.

What are the common drug interactions of Januvia and Ritalin, by gender? *:

female:

  1. Weight increased
  2. Abdominal discomfort
  3. Anxiety
  4. Arthropathy
  5. Dry throat
  6. Headache (pain in head)
  7. Lacrimation increased
  8. Musculoskeletal discomfort (discomfort in the body's muscles, joints, tendons, ligaments and nerves)
  9. Rash pruritic (redness with itching)
  10. Alopecia (absence of hair from areas of the body)

male:

  1. Arthralgia (joint pain)
  2. Neuropathy peripheral (surface nerve damage)
  3. Drug withdrawal syndrome (interfere with normal social, occupational, or other functioning. are not due to another medical condition, drug use, or discontinuation)
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Hepatic steatosis (fatty liver disease)
  7. Joint stiffness
  8. Weight decreased
  9. Adenocarcinoma pancreas (cancer of pancreas)
  10. Anxiety

What are the common drug interactions of Januvia and Ritalin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cough
  2. Nasopharyngitis (inflammation of the nasopharynx)

40-49:

  1. Confusional state
  2. Hypoglycaemia (deficiency of glucose in the bloodstream)
  3. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  4. Acute myocardial infarction (acute heart attack)
  5. Adjustment disorder
  6. Angina pectoris (chest pain due to ischemia of the heart muscle)
  7. Anxiety
  8. Biliary dyskinesia (motility disorder that affects the gallbladder and sphincter of oddi)
  9. Dizziness
  10. Hepatic steatosis (fatty liver disease)

50-59:

  1. Adverse event
  2. Anaemia (lack of blood)
  3. Ataxia (loss of full control of bodily movements)
  4. Blood glucose increased
  5. Cardiac failure congestive
  6. Chest pain
  7. Coronary artery bypass
  8. Diarrhoea
  9. Dry skin
  10. Dysphagia (a condition in which swallowing is difficult or painful)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Arthralgia (joint pain)
  3. Cough
  4. Dry mouth
  5. Embolism (obstruction of an artery, typically by a clot of blood or an air bubble)
  6. Eye haemorrhage (bleeding in the eye)
  7. Fatigue (feeling of tiredness)
  8. Haematocrit decreased
  9. Haemoglobin decreased
  10. Increased tendency to bruise (increased tendency to injure the underlying soft tissue or bone)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 33 people, 37.50%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 17 people, 19.32%
  3. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 15 people, 17.05%
  4. Type 2 Diabetes: 12 people, 13.64%
  5. High Blood Pressure: 12 people, 13.64%
  6. High Blood Cholesterol: 12 people, 13.64%
  7. Depression: 8 people, 9.09%
  8. Pain: 6 people, 6.82%
  9. Sleep Disorder: 5 people, 5.68%
  10. Multiple Myeloma (cancer of the plasma cells): 5 people, 5.68%

* Approximation only. Some reports may have incomplete information.

Do you take Januvia and Ritalin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Januvia and Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Januvia:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Ritalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Januvia and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ritalin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on sitagliptin phosphate and methylphenidate hydrochloride (the active ingredients of Januvia and Ritalin, respectively), and Januvia and Ritalin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: